Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oversubscribed Series C leads to $52.7mm for Aria Diagnostics

Executive Summary

Molecular diagnostics company Aria Diagnostics Inc. (formerly Tandem Diagnostics) has secured $52.7mm via an oversubscribed Series C venture round. New investors Meritech Capital Partners and an undisclosed mutual fund group were joined by current shareholders Venrock and Domain Associates.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies